黑料网

Diabetes mellitus; Oxidative stress; Reactive oxygen species; Insulin resistance; Stress signaling pathways; Pancreatic beta-cell dysfunction; Glucose homeostasis

Introduction

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from defects in insulin production or action. With its prevalence on the rise globally, understanding the underlying molecular mechanisms contributing to the development and progression of diabetes has become paramount. In recent years, oxidative stress has emerged as a key player in the pathogenesis of diabetes mellitus. This article aims to explore the intricate relationship between oxidative stress and diabetes, shedding light on the molecular mechanisms involved [1].

Mounting evidence suggests a strong link between oxidative stress and the pathogenesis of diabetes mellitus. Oxidative stress can arise from various sources, including excessive production of ROS, impaired antioxidant defense mechanisms, or both. ROS are highly reactive molecules that can cause cellular damage by oxidizing lipids, proteins, and DNA. This oxidative damage can have profound effects on cellular function and contribute to the development and progression of diabetes mellitus.

In this context, understanding the molecular mechanisms that link oxidative stress and diabetes mellitus is of great importance. Several key pathways have been implicated in this relationship, shedding light on the complex interplay between oxidative stress and the pathophysiology of diabetes mellitus [2].

One of the central mechanisms connecting oxidative stress and diabetes mellitus is the activation of stress-sensitive signaling pathways. Increased ROS production can trigger the activation of stress kinases such as c-Jun N-terminal kinase and nuclear factor kappa B. These kinases, in turn, can disrupt insulin signaling pathways and promote insulin resistance, a hallmark of type 2 diabetes. Additionally, oxidative stress-induced activation of NF-κB can lead to the production of proinflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-6, further exacerbating insulin resistance.

Furthermore, oxidative stress can impair pancreatic beta-cell function, contributing to the development of both type 1 and type 2 diabetes. Beta cells are responsible for producing and secreting insulin and their dysfunction or death leads to inadequate insulin production. Oxidative stress-induced damage to beta cells can occur through multiple mechanisms, including increased apoptosis, mitochondrial dysfunction, and altered gene expression [3].

Moreover, oxidative stress can disrupt glucose homeostasis by affecting insulin-sensitive tissues such as skeletal muscle, liver, and adipose tissue. Excessive ROS can interfere with insulin signaling pathways, leading to impaired glucose uptake and utilization in these tissues. This insulin resistance further contributes to hyperglycemia, a hallmark feature of diabetes mellitus.

Oxidative stress and diabetes mellitus

Oxidative stress refers to an imbalance between the production of reactive oxygen species and the body's ability to counteract their detrimental effects through antioxidant defense mechanisms. ROS, including superoxide anions, hydrogen peroxide, and hydroxyl radicals, are natural byproducts of cellular metabolism. While ROS play crucial roles in cell signaling and normal physiological processes, excessive production can lead to oxidative damage of cellular components such as lipids, proteins, and DNA [4].

Increased oxidative stress in diabetes

In diabetes, several factors contribute to the increased generation of ROS and subsequent oxidative stress. Elevated glucose levels, characteristic of both type 1 and type 2 diabetes, promote the formation of ROS through multiple pathways, including increased mitochondrial electron transport chain activity and advanced glycation end products formation. Additionally, hyperglycemia-induced activation of various enzymes, such as NADPH oxidase and xanthine oxidase, further enhances ROS production.

Molecular mechanisms of oxidative stress in diabetes

Activation of protein kinase C (PKC): High glucose levels trigger the activation of PKC, leading to the production of ROS through multiple pathways. PKC-mediated activation of NADPH oxidase contributes to increased ROS production, oxidative stress, and subsequent tissue damage [5].

Mitochondrial dysfunction: Hyperglycemia disrupts mitochondrial function, impairing the electron transport chain and leading to electron leakage, which generates excessive ROS. In turn, ROS-induced mitochondrial damage perpetuates oxidative stress and exacerbates diabetes-associated complications.

Advanced glycation end products (AGEs): AGEs are formed when glucose molecules react non enzymatically with proteins, lipids, or nucleic acids. AGEs induce oxidative stress by interacting with their receptor on various cell types, triggering ROS production through multiple intracellular signaling pathways [6].

Polyol Pathway: In hyperglycemic conditions, excess glucose is metabolized through the polyol pathway, involving the enzyme aldose reeducates. This pathway generates ROS as a byproduct, contributing to oxidative stress.

Consequences of oxidative stress in diabetes

Persistent oxidative stress has far-reaching consequences in diabetes, contributing to the development and progression of complications associated with the disease. Oxidative damage to cellular components and impaired antioxidant defense mechanisms can lead to endothelial dysfunction, inflammation, insulin resistance, beta-cell dysfunction, and impaired insulin signaling pathways. These processes further fuel the vicious cycle of oxidative stress, exacerbating diabetes-related complications such as cardiovascular disease, nephropathy, neuropathy, and retinopathy [7].

Discussion

The link between oxidative stress and diabetes mellitus is a complex and multifaceted relationship. Oxidative stress, characterized by the accumulation of reactive oxygen species, has been implicated in various aspects of diabetes mellitus, including insulin resistance, betacell dysfunction, and disrupted glucose homeostasis. In this discussion, we will delve into the molecular mechanisms that underlie these connections and explore their implications for the pathogenesis and management of diabetes mellitus.

Insulin resistance is a fundamental feature of type 2 diabetes, where target tissues fail to respond adequately to insulin. Oxidative stress has emerged as a key contributor to insulin resistance by disrupting insulin signaling pathways. Increased ROS production can activate stresssensitive kinases such as c-Jun N-terminal kinase and nuclear factor kappa B. These kinases can phosphorylate insulin receptor substrate proteins, impairing their ability to transduce insulin signaling. This leads to reduced glucose uptake and impaired insulin action in insulinresponsive tissues, such as skeletal muscle and adipose tissue. Moreover, the activation of NF-κB by oxidative stress promotes the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha and interleukin-6, which further contribute to insulin resistance by interfering with insulin signaling and promoting a chronic low-grade inflammatory state [8].

Oxidative stress also exerts detrimental effects on pancreatic beta cells, the key insulin-secreting cells in the islets of Langerhans. Betacell dysfunction and loss play a critical role in both type 1 and type 2 diabetes. ROS can directly damage beta cells by causing oxidative damage to lipids, proteins, and DNA. This can result in mitochondrial dysfunction, impaired insulin secretion, and increased beta-cell apoptosis. Additionally, oxidative stress can alter gene expression patterns in beta cells, leading to the dysregulation of crucial factors involved in insulin synthesis and secretion. The cumulative effect of these molecular changes is impaired beta-cell function and reduced insulin production, contributing to the progression of diabetes mellitus.

In addition to its impact on insulin resistance and beta-cell dysfunction, oxidative stress affects glucose homeostasis by disrupting insulin signaling in insulin-sensitive tissues. Skeletal muscle, liver, and adipose tissue are major players in glucose metabolism and are targeted by insulin to maintain normal blood glucose levels. Oxidative stress interferes with insulin signaling pathways, leading to impaired glucose uptake, reduced glycogen synthesis, and increased hepatic glucose production. These alterations further contribute to hyperglycemia, a hallmark of diabetes mellitus [9].

Understanding the molecular mechanisms linking oxidative stress and diabetes mellitus opens avenues for potential therapeutic interventions. Antioxidant strategies aimed at reducing ROS production or enhancing antioxidant defense mechanisms have shown promise in preclinical and clinical studies. Antioxidant compounds, such as vitamins C and E, as well as natural antioxidants found in fruits and vegetables, have demonstrated beneficial effects in improving insulin sensitivity and glycemic control. Furthermore, targeting stress signaling pathways, such as JNK and NF-κB, may provide therapeutic opportunities to mitigate oxidative stress-induced insulin resistance.

However, it is important to consider the complex nature of oxidative stress and its role in cellular signaling. ROS, in moderation, serve as important signaling molecules involved in physiological processes. Excessive reduction of oxidative stress may disrupt normal cellular function and compromise beneficial redox signaling pathways. Therefore, achieving an optimal balance in redox homeostasis is crucial when considering antioxidant-based therapeutic approaches [10].

Conclusion

Understanding the molecular mechanisms linking oxidative stress and diabetes mellitus is crucial for developing effective therapeutic strategies and interventions. Oxidative stress acts as a central player in the pathogenesis of diabetes, contributing to the development of complications and further impairing the body's ability to maintain glucose homeostasis. Targeting oxidative stress pathways may offer promising avenues for future research and the development of novel therapies aimed at mitigating diabetes-related complications and improving patient outcomes.

Conflict of Interest

None

Acknowledgement

None

1. Liu ZX, Liu SL, Yang HQ (2013) . J Comput Theor Nanosci 12: 3023-3027.

, ,

2. Li L, Luo Q, Xiao W (2016) . J Bioinform Comput Biol 15: 120-127.

, ,

3. Shao-Wu Z, Li-Yang H, Ting-He Z (2014) .  Int J Mol Sci 15: 3220-3233.

, ,

4. Ng SK, Zhuo Z, Soon-Heng T, Kui L (2003) . Nucleic Acids Res 31: 251-254.
5. Ng SK, Zhuo Z, Soon-Heng T, Kui L (2003) . Nucleic Acids Res 31: 251-254.

, ,

6. Musculoskeletal C, Wenham Y, Conaghan PG (2010) . Ther Adv Dis 2: 349-359.

, ,

7. Lajeunesse D, Massicotte F, Pelletier JP, Martel-Pelletier J (2003) . Mod Rheumatol 13: 7-14.

, ,

8. Jevsevar DS (2013) . J Am Acad Orthop Surg 21: 571-576.

, ,  

9. Vane JR (1971) . Nat. Cell Biol 231: 232-235.

, ,

10.  Scott DL, Berry H, Capell H (2000) .  Rheumatology 39: 1095-1101.

, ,

11. Shao-Wu Z, Li-Yang H, Ting-He Z (2014) .  Int J Mol Sci 15: 3220-3233.

, ,